$GAN
GAN Ltd Stock $gan

$gan Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223016222 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$33.76M	$35.13M	$37.49M
YoY Change	-3.46%	-6.31%	34.67%
Cost Of Revenue	$9.485M	$10.16M	$11.70M
YoY Change	-9.35%	-13.15%	34.17%
Gross Profit	$24.27M	$24.97M	$25.79M
YoY Change	-0.94%	-3.2%	34.91%
Gross Profit Margin	71.9%	71.08%	68.8%
Selling, General & Admin	$17.35M	$17.19M	$15.49M
YoY Change	-17.19%	10.97%	9.78%
% of Gross Profit	71.49%	68.85%	60.05%
Research & Development	$11.24M	$9.578M	$8.954M
YoY Change	116.62%	6.97%	84.62%
% of Gross Profit	46.3%	38.36%	34.71%
Depreciation & Amortization	$371.0K	$365.0K	$4.413M
YoY Change	-94.34%	-91.73%	11.36%
% of Gross Profit	1.53%	1.46%	17.11%
Operating Expenses	$17.35M	$17.19M	$28.86M
YoY Change	-17.19%	-40.43%	104.51%
Operating Profit	-$8.561M	-$6.001M	-$3.063M
YoY Change	-77.33%	95.92%	-19.44%
Interest Expense	$905.0K	$1.716M	$9.000K
YoY Change	-16.2%	18966.67%
% of Operating Profit
Other Income/Expense, Net	-$8.358M	$9.292M
YoY Change	-3195.56%
Pretax Income	-$17.82M	$1.575M	-$4.113M
YoY Change	-53.8%	-138.29%	8.24%
Income Tax	$585.0K	$74.00K	$386.0K
% Of Pretax Income		4.7%
Net Earnings	-$18.41M	$1.501M	-$4.499M
YoY Change	-52.0%	-133.36%	-19.8%
Net Earnings / Revenue	-54.53%	4.27%	-12.0%
Basic Earnings Per Share	-$0.42	$0.03	-$0.11
Diluted Earnings Per Share	-$0.42	$0.03	-$106.5K
COMMON SHARES
Basic Shares Outstanding	44.68M shares	43.14M shares	42.25M shares
Diluted Shares Outstanding	44.15M shares	47.20M shares	42.25M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$43.39M	$40.76M	$33.58M
YoY Change	-11.59%	21.36%	-35.66%
Cash & Equivalents	$43.40M	$40.80M	$33.58M
Short-Term Investments
Other Short-Term Assets	$3.454M	$3.111M	$7.763M
YoY Change	34.19%	-59.93%	126.79%
Inventory
Prepaid Expenses	$3.933M	$5.333M
Receivables	$10.15M	$13.87M	$7.840M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$60.93M	$63.07M	$49.19M
YoY Change	-9.54%	28.23%	-30.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.187M	$2.781M
YoY Change	30.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.123M	$3.642M	$9.691M
YoY Change	13.49%	-62.42%	146.84%
Total Long-Term Assets	$34.06M	$33.57M	$201.5M
YoY Change	-80.94%	-83.34%	-3.42%
TOTAL ASSETS
Total Short-Term Assets	$60.93M	$63.07M	$49.19M
Total Long-Term Assets	$34.06M	$33.57M	$201.5M
Total Assets	$94.98M	$96.64M	$250.7M
YoY Change	-61.39%	-61.45%	-10.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.815M	$5.603M	$5.775M
YoY Change	-23.18%	-2.98%	33.4%
Accrued Expenses	$13.45M	$10.61M	$12.27M
YoY Change	302.36%	-13.54%	178.07%
Deferred Revenue	$8.834M	$9.663M
YoY Change	1449.82%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$32.27M	$30.99M	$30.02M
YoY Change	17.64%	3.23%	16.69%
LONG-TERM LIABILITIES
Long-Term Debt	$39.77M	$28.48M	$0.00
YoY Change	43.73%
Other Long-Term Liabilities	$3.253M	$2.058M	$1.880M
YoY Change	140.25%	9.47%	236.31%
Total Long-Term Liabilities	$3.253M	$2.058M	$1.880M
YoY Change	140.25%	9.47%	236.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.27M	$30.99M	$30.02M
Total Long-Term Liabilities	$3.253M	$2.058M	$1.880M
Total Liabilities	$85.05M	$72.03M	$33.66M
YoY Change	10.43%	114.01%	18.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$291.8M	-$273.4M
YoY Change	142.74%
Common Stock	$334.4M	$330.8M
YoY Change	2.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.939M	$24.61M	$217.0M
YoY Change
Total Liabilities & Shareholders Equity	$94.98M	$96.64M	$250.7M
YoY Change	-61.39%	-61.45%	-10.15%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$18.41M	$1.501M	-$4.499M
YoY Change	-52.0%	-133.36%	-19.8%
Depreciation, Depletion And Amortization	$371.0K	$365.0K	$4.413M
YoY Change	-94.34%	-91.73%	11.36%
Cash From Operating Activities	$2.827M	-$4.175M	-$2.024M
YoY Change	-230.7%	106.27%	-51.17%
INVESTING ACTIVITIES
Capital Expenditures	$1.807M	$254.0K	-$3.988M
YoY Change	-159.79%	-106.37%	-1036.15%
Acquisitions
YoY Change
Other Investing Activities	$0.00		$0.00
YoY Change	-100.0%		-100.0%
Cash From Investing Activities	-$1.807M	-$1.762M	-$3.988M
YoY Change	-78.8%	-55.82%	-95.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.294M	-$47.00K
YoY Change	-95.2%
NET CHANGE
Cash From Operating Activities	2.827M	-$4.175M	-2.024M
Cash From Investing Activities	-1.807M	-$1.762M	-3.988M
Cash From Financing Activities	1.294M	-$47.00K
Net Change In Cash	2.314M	-$5.165M	$0.00
YoY Change	-85.79%		-100.0%
FREE CASH FLOW
Cash From Operating Activities	$2.827M	-$4.175M	-$2.024M
Capital Expenditures	$1.807M	$254.0K	-$3.988M
Free Cash Flow	$1.020M	-$4.429M	$1.964M
YoY Change	18.74%	-325.51%	-142.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts		usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39274
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	GAN Limited
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Spectrum Center Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1900
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92618
CY2023Q1	dei	City Area Code CityAreaCode	(833)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	565-0550
CY2023Q1	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	Not applicable
CY2023Q1	dei	Security12b Title Security12bTitle	Ordinary shares, par value $0.01
CY2023Q1	dei	Trading Symbol TradingSymbol	GAN
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44683390	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40755000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45920000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	119000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	250000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13873000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13808000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5333000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4861000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3111000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3041000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	63072000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	67630000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7756000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6749000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22167000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24955000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3642000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3746000	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001799332
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges		usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q1	GAN	Deferred Income Tax DeferredIncomeTax		usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense		usd
CY2022Q1	GAN	Increase Decrease In Accrued Content License Fees IncreaseDecreaseInAccruedContentLicenseFees		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2023Q1	us-gaap	Assets Assets	96637000	usd
CY2022Q4	us-gaap	Assets Assets	103080000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5603000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6437000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8864000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8750000	usd
CY2023Q1	GAN	Accrued Content License Fees AccruedContentLicenseFees	1748000	usd
CY2022Q4	GAN	Accrued Content License Fees AccruedContentLicenseFees	2214000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9663000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10683000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5115000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4448000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	30993000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32532000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4107000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4218000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	28483000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	28157000	usd
CY2023Q1	GAN	Content Licensing Liability ContentLicensingLiability	6389000	usd
CY2022Q4	GAN	Content Licensing Liability ContentLicensingLiability	15280000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2058000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1343000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2125000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	72030000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	82312000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43280958	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43280958	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42894211	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42894211	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	433000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	429000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q1	GAN	Intangible Assets Acquired In Business Acquisition IntangibleAssetsAcquiredInBusinessAcquisition		usd
CY2023Q1	GAN	Accrued Liability Settled Through Issuance Of Shares AccruedLiabilitySettledThroughIssuanceOfShares		usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	330366000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	328998000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-273360000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274861000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32832000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33798000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1501000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	24607000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20768000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96637000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	103080000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35129000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37494000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	10161000	usd
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	11700000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7184000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6098000	usd
CY2023Q1	GAN	Product And Technology Expense ProductAndTechnologyExpense	9578000	usd
CY2022Q1	GAN	Product And Technology Expense ProductAndTechnologyExpense	8954000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10006000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9392000	usd
CY2022Q1	us-gaap	Restructuring Charges RestructuringCharges	1059000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4201000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4413000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	41130000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	41616000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6001000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4122000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1716000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	-9000	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	9292000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1575000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4113000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	386000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1501000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4499000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42982255	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42252661	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47200182	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42252661	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1501000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4499000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	966000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4264000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2467000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8763000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20768000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20768000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	966000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1382000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	4000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	79000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	65000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	24607000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	24607000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	224037000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	224037000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4499000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4499000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4264000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1316000	usd
CY2022Q1	GAN	Adjustments To Additional Paid In Capital Accrued Liability Settled Through Issuance Of Shares AdjustmentsToAdditionalPaidInCapitalAccruedLiabilitySettledThroughIssuanceOfShares	444000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	217034000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	217034000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1501000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4499000	usd
CY2023Q1	GAN	Amortization Of Software And Intangible Assets AmortizationOfSoftwareAndIntangibleAssets	3835000	usd
CY2022Q1	GAN	Amortization Of Software And Intangible Assets AmortizationOfSoftwareAndIntangibleAssets	4082000	usd
CY2023Q1	GAN	Depreciation On Property And Equipment And Finance Lease Rightofuse Assets DepreciationOnPropertyAndEquipmentAndFinanceLeaseRightofuseAssets	365000	usd
CY2022Q1	GAN	Depreciation On Property And Equipment And Finance Lease Rightofuse Assets DepreciationOnPropertyAndEquipmentAndFinanceLeaseRightofuseAssets	331000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	326000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1362000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1222000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	9292000	usd
CY2023Q1	GAN	Deferred Income Tax DeferredIncomeTax	-194000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	181000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-143000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-237000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	404000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	670000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	32000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	267000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-39000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-238000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-916000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	591000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-7000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2885000	usd
CY2023Q1	GAN	Increase Decrease In Accrued Content License Fees IncreaseDecreaseInAccruedContentLicenseFees	-498000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1213000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	22000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	660000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-183000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	331000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-243000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4175000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3543000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	165000	usd
CY2022Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	16000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2024000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-1517000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	254000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	429000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1762000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3988000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	65000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	112000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	819000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5165000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5894000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45920000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39477000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40755000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33583000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1068000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2444000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	36000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	728000	usd
CY2022Q1	GAN	Intangible Assets Acquired In Business Acquisition IntangibleAssetsAcquiredInBusinessAcquisition	24876000	usd
CY2022Q1	GAN	Accrued Liability Settled Through Issuance Of Shares AccruedLiabilitySettledThroughIssuanceOfShares	913000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_807_eus-gaap--NatureOfOperations_zBNiClqDNvrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 </b>— <b><span id="xdx_82F_zvMgIWzQZTOh">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GAN Limited (the “Parent,” and with its subsidiaries, collectively the “Company”) is an exempted company limited by shares, incorporated and registered in Bermuda.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a business-to-business (“B2B”) supplier of a proprietary gaming system, GameSTACK™ (“GameSTACK”), which is used predominately by the U.S. land-based casino industry. For its B2B customers, GameSTACK is a turnkey technology solution for regulated real money internet gambling (“real money iGaming” or “RMiG”), online sports gaming, and virtual simulated gaming (“SIM”). In addition, the Company’s B2B segment offers GAN Sports, an in-house online and retail sports betting technology platform, through internet connected self-service kiosks deployed at casino properties and mobile solutions. The Company is also a business-to-consumer (“B2C”) developer and operator of an online sports betting and casino platform under its “Coolbet” brand, providing international users with access through www.coolbet.com to its sportsbook, casino games and poker products. The Company operates its B2C segment in markets across Northern Europe, Latin America, and Canada.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-273400000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40800000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9663000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	28483000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1394000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	326000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3447155	shares
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_z7s28a5qiks8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zEH5VJ5YcUq1">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Due to the inherent uncertainties involved in making estimates, actual results could differ from the original estimates, and may require significant adjustments to these reported balances in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	624000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	867000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zPtE0bPps3Gk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_znNceaD4SYC6">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of its cash and trade receivables. The Company holds cash deposits in foreign countries, primarily in Northern Europe and Latin America, of approximately $<span id="xdx_90F_eus-gaap--Deposits_iI_pn5n6_c20230331__srt--StatementGeographicalAxis__custom--NorthernEuropeAndLatinAmericaMember_zTQc6YgCRie" title="Cash deposits">36.9</span> million, which are subject to local banking laws and may bear higher or lower risk than cash deposited in the United States. Cash held in the United States is maintained in a major financial institution in excess of federally insured limits. As part of our cash management processes, the Company performs periodic evaluations of the credit standing of the financial institutions and we have not sustained any credit losses from instruments held at these financial institutions. Additionally, the Company maintains an allowance for potential credit losses, but historically has not experienced any significant losses related to individual customers or groups of customers in any particular geographic area.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GAN LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in thousands, except share and per share amounts)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	9700000	usd
CY2023Q1	GAN	Amounts Due To Customers Current AmountsDueToCustomersCurrent	1582000	usd
CY2022Q4	GAN	Amounts Due To Customers Current AmountsDueToCustomersCurrent	1628000	usd
CY2023Q1	GAN	Number Of Third Party Gaming Products Available NumberOfThirdPartyGamingProductsAvailable	4700	integer
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.12
CY2023Q1	GAN	Weighted Average Contractual Term Outstanding Beginning WeightedAverageContractualTermOutstandingBeginning	P6Y7M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1139000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	367870	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.01
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9663000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10683000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	245151	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	14.31
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3569874	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.83
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6793000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6449000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4012000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3599000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2781000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2850000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	365000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	310000	usd
CY2022Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.095	pure
CY2022Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2026-10-26
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	2400000	usd
CY2023Q1	GAN	Capitalized Computer Software Gross Excluding Development In Progress CapitalizedComputerSoftwareGrossExcludingDevelopmentInProgress	8588000	usd
CY2022Q4	GAN	Capitalized Computer Software Gross Excluding Development In Progress CapitalizedComputerSoftwareGrossExcludingDevelopmentInProgress	6857000	usd
CY2023Q1	GAN	Capitalized Computer Software In Progress Development CapitalizedComputerSoftwareInProgressDevelopment	514000	usd
CY2022Q4	GAN	Capitalized Computer Software In Progress Development CapitalizedComputerSoftwareInProgressDevelopment	732000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	9102000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	7589000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	1346000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	840000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7756000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6749000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	486000	usd
CY2022Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1162000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	49809000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27642000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22167000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	48727000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23772000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24955000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3349000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2920000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	10351000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3072000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2921000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2490000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1709000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1624000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	27600000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M9D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1356000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2402269	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.87
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y11M12D
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.1546	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	436000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.70
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.12
CY2022Q1	us-gaap	Restructuring Costs RestructuringCosts	1059000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4201000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4413000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1716000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	9000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9292000	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1575000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6120	pure
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0174	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50	pure
CY2023Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04	pure
CY2023Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	178000	usd
CY2022Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	173000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1501000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4499000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42982255	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42252661	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47200182	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42252661	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-4113000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35129000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37494000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2117000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1874000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2655000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	223000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	296000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35129000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37494000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	10161000	usd
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	11700000	usd
CY2023Q1	GAN	Segment Contribution SegmentContribution	24968000	usd
CY2022Q1	GAN	Segment Contribution SegmentContribution	25794000	usd
CY2023Q1	GAN	Segment Contribution SegmentContribution	24968000	usd
CY2022Q1	GAN	Segment Contribution SegmentContribution	25794000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7184000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6098000	usd
CY2023Q1	GAN	Product And Technology Expense ProductAndTechnologyExpense	9578000	usd
CY2022Q1	GAN	Product And Technology Expense ProductAndTechnologyExpense	8954000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10006000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9392000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35129000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37494000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35129000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37494000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.047	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.094	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	30000000.0	usd

Files In Submission

Name	View Source	Status
gan-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-016222-index-headers.html	Edgar Link	pending
0001493152-23-016222-index.html	Edgar Link	pending
0001493152-23-016222.txt	Edgar Link	pending
0001493152-23-016222-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
gan-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
gan-20230331_pre.xml	Edgar Link	unprocessable
gan-20230331_lab.xml	Edgar Link	unprocessable
gan-20230331_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GAN
GAN Ltd Stock $gan

2023 Q2 Form 10-Q Financial Statement

#000149315223016222 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GAN GAN Ltd Stock $gan

2023 Q2 Form 10-Q Financial Statement

#000149315223016222 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GAN
GAN Ltd Stock $gan